Table 2.
Factors related to the increased RDW (>14.9%) at post-TPL 3 months.
| Variables | aAdjusted OR (95% CI) | P |
|---|---|---|
| Age (1-year increment) | 1.01 (1.01–1.02) | 0.002 |
| Male sex (vs. female) | 1.71 (1.37–2.12) | <0.001 |
| Body mass index (1 kg/m2 increment) | 1.02 (0.99–1.05) | 0.24 |
| Smoking (vs. never) | 1.31 (1.03–1.65) | 0.03 |
| Diabetes mellitus (vs. none) | 1.09 (0.85–1.39) | 0.49 |
| Post-TPL 3 month eGFR < 30 mL/min/1.73 m2 (vs. eGFR ≥ 30 mL/min/1.73 m2) | 0.75 (0.54–1.05) | 0.09 |
| Underlying primary glomerulopathy (.vs other cause of ESRD) | 0.83 (0.66–1.06) | 0.13 |
| Hemoglobin (1 g/dL increment) | 0.69 (0.65–0.73) | <0.001 |
| Hypoalbuminemia (<3.0 g/dL) | 2.18 (1.16–4.11) | 0.02 |
| Deceased donor (.vs other donor relationship) | 1.25 (1.00–1.55) | 0.05 |
| Number of mismatched HLA (one antigen increment) | 1.02 (0.96–1.08) | 0.57 |
| Acute rejection within 3 months (vs. none) | 1.17 (0.86–1.61) | 0.32 |
| Induction therapy (vs. none) | 1.49 (1.21–1.83) | <0.001 |
| Use of tacrolimus (vs. no use) | 0.56 (0.46–0.69) | <0.001 |
OR, odds ratio, CI, confidence interval, eGFR, estimated glomerular filtration rate, ESRD, end stage renal disease, HLA, human leukocyte antigen, TPL, transplantation. Missing data was imputed by multiple imputation by classification and regression trees (CART) method. aAll variables in the Table 2 were simultaneously adjusted, and odds ratio/confidence interval of each characteristic was shown.